One possible mechanism responsible for the more aggressive behavior of cancers and worse clinical outcomes with cells expressing OCT4 is the presence of the stem cell phenotype in cancers related to OCT4-mediated dedifferentiation [20] and related chemoresistance [21,22,23]. This evidence concerns the gene POU5F1 and cancer.